Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6350
+0.0050 (0.31%)
NASDAQ· Last Trade: Jun 8th, 10:57 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors